These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
259 related articles for article (PubMed ID: 29021946)
1. Predictors of pneumococcal carriage and the effect of the 13-valent pneumococcal conjugate vaccination in the Western Australian Aboriginal population. Collins DA; Hoskins A; Snelling T; Senasinghe K; Bowman J; Stemberger NA; Leach AJ; Lehmann D Pneumonia (Nathan); 2017; 9():14. PubMed ID: 29021946 [TBL] [Abstract][Full Text] [Related]
2. High nasopharyngeal carriage of non-vaccine serotypes in Western Australian aboriginal people following 10 years of pneumococcal conjugate vaccination. Collins DA; Hoskins A; Bowman J; Jones J; Stemberger NA; Richmond PC; Leach AJ; Lehmann D PLoS One; 2013; 8(12):e82280. PubMed ID: 24349245 [TBL] [Abstract][Full Text] [Related]
3. Impact of 13-Valent Pneumococcal Conjugate Vaccination on Streptococcus pneumoniae Carriage in Young Children in Massachusetts. Lee GM; Kleinman K; Pelton SI; Hanage W; Huang SS; Lakoma M; Dutta-Linn M; Croucher NJ; Stevenson A; Finkelstein JA J Pediatric Infect Dis Soc; 2014 Mar; 3(1):23-32. PubMed ID: 24567842 [TBL] [Abstract][Full Text] [Related]
4. Pneumococcal carriage and invasive disease in children before introduction of the 13-valent conjugate vaccine: comparison with the era before 7-valent conjugate vaccine. Sharma D; Baughman W; Holst A; Thomas S; Jackson D; da Gloria Carvalho M; Beall B; Satola S; Jerris R; Jain S; Farley MM; Nuorti JP Pediatr Infect Dis J; 2013 Feb; 32(2):e45-53. PubMed ID: 23080290 [TBL] [Abstract][Full Text] [Related]
5. Serotype distribution and antimicrobial susceptibilities of nasopharyngeal isolates of Streptococcus pneumoniae from healthy children in the 13-valent pneumococcal conjugate vaccine era. Zuccotti G; Mameli C; Daprai L; Garlaschi ML; Dilillo D; Bedogni G; Faccini M; Gramegna M; Torresani E; ; Ballerini E; Benincaso A; Bonvissuto M; Bricalli D; Brioschi M; Calloni CS; Camiletti MI; Colella G; De Angelis L; Decarlis S; Di Nello F; Dozzi M; Galli E; Gandini V; Giuliani MG; Laviola F; Loda B; Macedoni M; Mazzucchi E; Metta MG; Moscatiello A; Nannini P; Petruzzi M; Picicco D; Picciotti M; Pisanelli S; Porta N; Ramponi G; Redaelli F; Rubini R; Sala N; Saitta V; Scelza G; Tiso RM; Tomasetto M; Torcoletti M; Travaini M; Valentini M; Vessia C Vaccine; 2014 Jan; 32(5):527-34. PubMed ID: 24342249 [TBL] [Abstract][Full Text] [Related]
6. Pneumococcal carriage in children and adults two years after introduction of the thirteen valent pneumococcal conjugate vaccine in England. van Hoek AJ; Sheppard CL; Andrews NJ; Waight PA; Slack MP; Harrison TG; Ladhani SN; Miller E Vaccine; 2014 Jul; 32(34):4349-55. PubMed ID: 24657717 [TBL] [Abstract][Full Text] [Related]
7. Dynamics of pneumococcal carriage among day-care center attendees during the transition from the 7-valent to the higher-valent pneumococcal conjugate vaccines in Greece. Grivea IN; Priftis KN; Giotas A; Kotzia D; Tsantouli AG; Douros K; Michoula AN; Syrogiannopoulos GA Vaccine; 2014 Nov; 32(48):6513-20. PubMed ID: 25252194 [TBL] [Abstract][Full Text] [Related]
8. Decline in Pneumococcal Nasopharyngeal Carriage of Vaccine Serotypes After the Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in Children in Atlanta, Georgia. Desai AP; Sharma D; Crispell EK; Baughman W; Thomas S; Tunali A; Sherwood L; Zmitrovich A; Jerris R; Satola SW; Beall B; Moore MR; Jain S; Farley MM Pediatr Infect Dis J; 2015 Nov; 34(11):1168-74. PubMed ID: 26226445 [TBL] [Abstract][Full Text] [Related]
9. Changes in Streptococcus pneumoniae serotype distribution in invasive disease and nasopharyngeal carriage after the heptavalent pneumococcal conjugate vaccine introduction in Bogotá, Colombia. Parra EL; De La Hoz F; Díaz PL; Sanabria O; Realpe ME; Moreno J Vaccine; 2013 Aug; 31(37):4033-8. PubMed ID: 23680440 [TBL] [Abstract][Full Text] [Related]
10. Pneumococcal carriage in young children one year after introduction of the 13-valent conjugate vaccine in Italy. Camilli R; Daprai L; Cavrini F; Lombardo D; D'Ambrosio F; Del Grosso M; Vescio MF; Landini MP; Pascucci MG; Torresani E; Garlaschi ML; Sambri V; Pantosti A PLoS One; 2013; 8(10):e76309. PubMed ID: 24124543 [TBL] [Abstract][Full Text] [Related]
11. Impact of pneumococcal conjugate vaccines on burden of invasive pneumococcal disease and serotype distribution of Streptococcus pneumoniae isolates: an overview from Kuwait. Mokaddas E; Albert MJ Vaccine; 2012 Dec; 30 Suppl 6():G37-40. PubMed ID: 23228356 [TBL] [Abstract][Full Text] [Related]
12. Emerging Streptococcus pneumoniae Strains Colonizing the Nasopharynx in Children After 13-valent Pneumococcal Conjugate Vaccination in Comparison to the 7-valent Era, 2006-2015. Kaur R; Casey JR; Pichichero ME Pediatr Infect Dis J; 2016 Aug; 35(8):901-6. PubMed ID: 27420806 [TBL] [Abstract][Full Text] [Related]
13. The impact of a pneumococcal conjugate vaccination program on the nasopharyngeal carriage, serotype distribution and antimicrobial resistance of Streptococcus pneumoniae among healthy children in Turkey. Soysal A; Karabağ-Yılmaz E; Kepenekli E; Karaaslan A; Cagan E; Atıcı S; Atınkanat-Gelmez G; Boran P; Merdan S; Hasdemir U; Söyletir G; Bakır M Vaccine; 2016 Jul; 34(33):3894-900. PubMed ID: 27269059 [TBL] [Abstract][Full Text] [Related]
14. Effects of PCV7 and PCV13 on invasive pneumococcal disease and carriage in Stockholm, Sweden. Galanis I; Lindstrand A; Darenberg J; Browall S; Nannapaneni P; Sjöström K; Morfeldt E; Naucler P; Blennow M; Örtqvist Å; Henriques-Normark B Eur Respir J; 2016 Apr; 47(4):1208-18. PubMed ID: 26797033 [TBL] [Abstract][Full Text] [Related]
15. Pneumococcal nasopharyngeal carriage in children <5 years of age visiting the pediatric emergency room in relation to PCV7 and PCV13 introduction in southern Israel. Ben-Shimol S; Givon-Lavi N; Greenberg D; Dagan R Hum Vaccin Immunother; 2016; 12(2):268-76. PubMed ID: 26430921 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of 13-valent pneumococcal conjugate vaccine (PCV13) versus that of 7-valent PCV (PCV7) against nasopharyngeal colonization of antibiotic-nonsusceptible Streptococcus pneumoniae. Dagan R; Juergens C; Trammel J; Patterson S; Greenberg D; Givon-Lavi N; Porat N; Gurtman A; Gruber WC; Scott DA J Infect Dis; 2015 Apr; 211(7):1144-53. PubMed ID: 25355940 [TBL] [Abstract][Full Text] [Related]
17. Increased carriage of non-vaccine serotypes with low invasive disease potential four years after switching to the 10-valent pneumococcal conjugate vaccine in The Netherlands. Vissers M; Wijmenga-Monsuur AJ; Knol MJ; Badoux P; van Houten MA; van der Ende A; Sanders EAM; Rots NY PLoS One; 2018; 13(3):e0194823. PubMed ID: 29601605 [TBL] [Abstract][Full Text] [Related]
18. Nasopharyngeal carriage of otitis media pathogens in infants receiving 10-valent non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10), 13-valent pneumococcal conjugate vaccine (PCV13) or a mixed primary schedule of both vaccines: A randomised controlled trial. Beissbarth J; Wilson N; Arrowsmith B; Binks MJ; Oguoma VM; Lawrence K; Llewellyn A; Mulholland EK; Santosham M; Morris PS; Smith-Vaughan HC; Cheng AC; Leach AJ Vaccine; 2021 Apr; 39(16):2264-2273. PubMed ID: 33766422 [TBL] [Abstract][Full Text] [Related]
19. General health, otitis media, nasopharyngeal carriage and middle ear microbiology in Northern Territory Aboriginal children vaccinated during consecutive periods of 10-valent or 13-valent pneumococcal conjugate vaccines. Leach AJ; Wigger C; Beissbarth J; Woltring D; Andrews R; Chatfield MD; Smith-Vaughan H; Morris PS Int J Pediatr Otorhinolaryngol; 2016 Jul; 86():224-32. PubMed ID: 27260611 [TBL] [Abstract][Full Text] [Related]
20. Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway. Steens A; Bergsaker MA; Aaberge IS; Rønning K; Vestrheim DF Vaccine; 2013 Dec; 31(52):6232-8. PubMed ID: 24176490 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]